Cwm LLC Sells 5,207 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Cwm LLC lessened its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 52.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,692 shares of the company’s stock after selling 5,207 shares during the period. Cwm LLC’s holdings in Inspire Medical Systems were worth $747,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Huntington National Bank grew its stake in Inspire Medical Systems by 228.3% in the 4th quarter. Huntington National Bank now owns 174 shares of the company’s stock worth $32,000 after buying an additional 121 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of Inspire Medical Systems by 356.5% in the 1st quarter. Parallel Advisors LLC now owns 210 shares of the company’s stock valued at $33,000 after purchasing an additional 164 shares in the last quarter. True Wealth Design LLC boosted its stake in shares of Inspire Medical Systems by 39.0% in the 4th quarter. True Wealth Design LLC now owns 196 shares of the company’s stock valued at $36,000 after purchasing an additional 55 shares in the last quarter. Harbour Investments Inc. raised its holdings in Inspire Medical Systems by 101.0% during the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock valued at $37,000 after buying an additional 99 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its holdings in Inspire Medical Systems by 61.9% during the 4th quarter. Quadrant Capital Group LLC now owns 327 shares of the company’s stock valued at $61,000 after buying an additional 125 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

INSP has been the topic of several recent analyst reports. KeyCorp cut their price objective on shares of Inspire Medical Systems from $216.00 to $197.00 and set an “overweight” rating on the stock in a research report on Tuesday. Royal Bank Of Canada dropped their price objective on shares of Inspire Medical Systems from $260.00 to $215.00 and set an “outperform” rating on the stock in a report on Tuesday, April 15th. Wells Fargo & Company lowered their price target on shares of Inspire Medical Systems from $195.00 to $174.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Wall Street Zen raised shares of Inspire Medical Systems from a “hold” rating to a “buy” rating in a report on Saturday, July 12th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Inspire Medical Systems from $235.00 to $195.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $208.55.

Insider Activity

In related news, Director Shawn Mccormick sold 360 shares of the stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $160.00, for a total transaction of $57,600.00. Following the completion of the transaction, the director directly owned 24,046 shares of the company’s stock, valued at approximately $3,847,360. This represents a 1.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.30% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of NYSE INSP opened at $129.43 on Wednesday. The firm has a market cap of $3.82 billion, a price-to-earnings ratio of 59.65, a P/E/G ratio of 1.91 and a beta of 1.25. The business’s 50-day simple moving average is $136.24 and its 200-day simple moving average is $159.24. Inspire Medical Systems, Inc. has a 52 week low of $123.00 and a 52 week high of $225.00.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Monday, May 5th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.33. Inspire Medical Systems had a return on equity of 10.00% and a net margin of 7.92%. The company had revenue of $201.32 million during the quarter, compared to analysts’ expectations of $194.89 million. During the same period last year, the business earned ($0.34) earnings per share. The business’s revenue was up 22.7% on a year-over-year basis. As a group, equities research analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.